Carmine Therapeutics, an EVX founded biotech company and emerging leader in non-viral gene therapies, announced the first Closing of its Series A financing. All...
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, announced that it has received approval in Australia from the...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, presented data from the Phase 3 PREVENT-19 trial...
Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive...
